Does Olezarsen / Plozasiran (ApoC-III inhibitors) work?

Read Off Label rates the evidence for Olezarsen / Plozasiran (ApoC-III inhibitors) as Strong and the benefit magnitude as high, producing an overall grade of B (6.8/10). Olezarsen (Ionis/Sobi) approved in US and EU for familial chylomicronemia syndrome.

Is Olezarsen / Plozasiran (ApoC-III inhibitors) safe?

Olezarsen / Plozasiran (ApoC-III inhibitors) has a med risk profile in published human data. Legal status: Rx (olezarsen approved US/EU for FCS as Tryngolza); severe HTG under FDA review. This is not medical advice — see the disclaimer.

Rankings / Metabolic Health

Olezarsen / Plozasiran (ApoC-III inhibitors)

Metabolic Health · ApoC-III inhibitor (antisense / siRNA)

Tier B

Reviewed by Read Off Label · Last reviewed Jun 7, 2026 · How we grade

apoc3rna-therapyantisensehypertriglyceridemiaawaiting-readoutprescription

6.8 / 10

Tier B

Ev 8 Bn 8 Sf 5

Bottom line

Read Off Label grades Olezarsen / Plozasiran (ApoC-III inhibitors) as B (6.8/10) based on strong evidence, high benefit magnitude, and a med-risk safety profile.

Olezarsen (Ionis/Sobi) approved in US and EU for familial chylomicronemia syndrome.

Typical use: Olezarsen 80 mg SC monthly; plozasiran SC quarterly — Rx (olezarsen approved US/EU for FCS as Tryngolza); severe HTG under FDA review.

What this is

Olezarsen (Ionis/Sobi) approved in US and EU for familial chylomicronemia syndrome. sNDA for severe hypertriglyceridemia under FDA Priority Review, PDUFA June 30 2026: pooled CORE/CORE2 Phase 3 showed triglycerides -66% and acute pancreatitis events -85%. Plozasiran (Arrowhead) siRNA in Phase 3 (SHASTA) for the same population. Industry-sponsored.

Mechanism

Hepatic apoC-III knockdown (olezarsen = antisense oligonucleotide; plozasiran = siRNA) de-represses lipoprotein lipase, accelerating triglyceride clearance, a route distinct from statins and fibrates.

Dose & route

Olezarsen 80 mg SC monthly; plozasiran SC quarterly

Citations

Links go to the source. If a link is dead or you want something re-checked, let me know.

Common questions

Does Olezarsen / Plozasiran (ApoC-III inhibitors) work?: Read Off Label rates the evidence for Olezarsen / Plozasiran (ApoC-III inhibitors) as Strong and the benefit magnitude as high, producing an overall grade of B (6.8/10). Olezarsen (Ionis/Sobi) approved in US and EU for familial chylomicronemia syndrome.
Is Olezarsen / Plozasiran (ApoC-III inhibitors) safe?: Olezarsen / Plozasiran (ApoC-III inhibitors) has a med risk profile in published human data. Legal status: Rx (olezarsen approved US/EU for FCS as Tryngolza); severe HTG under FDA review. This is not medical advice — see the disclaimer.
What is the typical dose for Olezarsen / Plozasiran (ApoC-III inhibitors)?: Olezarsen 80 mg SC monthly; plozasiran SC quarterly
How does Olezarsen / Plozasiran (ApoC-III inhibitors) work?: Hepatic apoC-III knockdown (olezarsen = antisense oligonucleotide; plozasiran = siRNA) de-represses lipoprotein lipase, accelerating triglyceride clearance, a route distinct from statins and fibrates.

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.